Corcept Therapeutics - Chart Of The Day -

Corcept Therapeutics – Chart Of The Day

Mar 13, 2017Jeremy ParkinsonFinance0

Summary

14 new highs and up 27.78% in the last month

100% technical buy signals

Earnings estimated to increase 53.80% next year

Corcept Therapeutics (CORT) Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.

The status of Barchart’s Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore, change during the day as the market fluctuates.

Barchart technical indicators:

100% technical buy signals

Trend Spotter buy signal

Above its 20, 50 and 100 day moving averages

14 new highs and up 27.78% in the last month

Relative Strength Index 79.42%

Technical support level at 10.2

Recently traded at 11.00 with a 50 day moving average of 8.27

Fundamental factors:

Market Cap $1.23 billion

P/E 110.56

Revenue expected to grow 51.90% this year and another 38.70% next year